Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Agborsangaya CB et al. |
Association between Epstein-Barr virus infection and risk for development of pregnancy-associated breast cancer: joint effect with vitamin D?
|
|
2 |
Barok M et al. |
Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer.
|
|
3 |
Barok M et al. |
Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo.
|
|
4 |
Hautamäki-Lamminen K et al. |
Syöpäpotilaat ja seksuaalisuuteen liittyvät tiedontarpeet.
|
|
5 |
Joensuu H et al. |
Very high quantitative tumor HER2 content and outcome in early breast cancer.
|
|
6 |
Junttila TT et al. |
Vasta-aineisiin konjugoidut solunsalpaajat tulossa syövän hoitoon.
|
|
7 |
Kellokumpu-Lehtinen P et al. |
Anaemia: a rare but neglected problem among Finnish patients receiving chemotherapy for solid tumours.
|
|
8 |
Konsti J et al. |
Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer.
|
|
9 |
Koskinen MJ et al. |
Intraepidermal nerve fibre density in cancer patients receiving adjuvant chemotherapy.
|
|
10 |
Lehtimäki T et al. |
Long-term prognosis of breast cancer detected by mammography screening or other methods.
|
|
11 |
Lehto US et al. |
Impact of life on survival of patient with localized melanoma.
|
|
12 |
Peltoniemi P et al. |
The effect of hospital volume on the outcome of breast cancer surgery.
|
|
13 |
Pelttari LM et al. |
RAD51C is a susceptibility gene for ovarian cancer.
|
|
14 |
Penttinen HM et al. |
Quality of life and physical performance and activity of breast cancer patients after adjuvant treatments.
|
|
15 |
Rappu P et al. |
Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay.
|
|
16 |
Rossi M et al. |
PET imaging in a longitudinal non-Hodgkin's lymphoma study: association with tumor volume.
|
|
17 |
Salonen P et al. |
Changes in quality of life in patients with breast cancer.
|
|
18 |
Salonen P et al. |
Individual face-to-face support and quality of life in patients with breast cancer.
|
|
19 |
Sihto H et al. |
Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.
|
|
20 |
Smith IE et al. |
First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients.
|
|
21 |
Soimakallio S et al. |
Clinical audit: Development of the criteria of good practices.
|
|
22 |
Vihinen PP et al. |
Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab.
|
|
23 |
Wahlin BE et al. |
T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab.
|
|
24 |
Wu X et al. |
Early Treatment Response Evaluation in Patients with Diffuse Large B-Cell Lymphoma-A Pilot Study Comparing Volumetric MRI and PET/CT.
|
|
25 |
Wu X et al. |
Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma - a pilot study: comparison with 2-deoxy-2-fluoro- D-glucose-positron emission tomography/computed tomography.
|
|
26 |
Wu X et al. |
No correlation between glucose metabolism and apparent diffusion coefficient in diffuse large B-cell lymphoma: A PET/CT and DW-MRI study.
|